UL Solutions expands testing capabilities as Eurofins realigns portfolio strategy.
Eurofins Scientific has agreed to divest its electrical and electronic testing division to UL Solutions in a transaction valued at €575 million ($677 million), marking a significant portfolio reshaping move by the French laboratory services group.
The deal includes Eurofins’ MET Labs business and forms part of the company’s broader strategy to concentrate on its core testing activities spanning food safety, environmental analysis, and pharmaceutical services. By exiting the electrical testing segment, Eurofins aims to redirect capital toward areas where it sees stronger long-term growth potential.
Investor sentiment turned positive following the announcement, with Eurofins shares rising over 4 percent in early trading, reflecting market approval of the company’s strategic realignment.
Eurofins said the proceeds from the sale will support multiple financial objectives, including debt reduction and share buyback programs. The company also plans to channel funds into strategic acquisitions and increased investments in artificial intelligence and robotics to enhance laboratory automation and operational efficiency.
The divestment comes as testing and certification companies increasingly streamline portfolios to focus on specialized, high-value segments while improving financial flexibility. Eurofins reiterated that the transaction remains aligned with its previously announced mid-term strategy and financial targets through 2027.
The acquisition will expand UL Solutions’ capabilities in electrical and electronic product testing and certification, strengthening its position in safety and compliance services across global markets.
The transaction is expected to close by the end of 2026, subject to customary regulatory approvals and completion conditions, after which Eurofins will continue advancing its core life sciences testing strategy.
